Hiroko Isoda Selected Research

hirsein A

7/2012

Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroko Isoda Research Topics

Disease

18	Neoplasms (Cancer) 04/2024 - 12/2007
16	Leukemia 09/2014 - 01/2002
13	Melanoma (Melanoma, Malignant) 01/2020 - 12/2007
9	Breast Neoplasms (Breast Cancer) 01/2017 - 08/2002
8	Fibrosis (Cirrhosis) 02/2024 - 10/2013
8	Inflammation (Inflammations) 09/2023 - 01/2018
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2011
8	Hypersensitivity (Allergy) 10/2013 - 01/2008
7	Experimental Melanoma 10/2022 - 05/2009
7	Neuroblastoma 01/2020 - 01/2011
6	Obesity 01/2024 - 01/2013
6	Insulin Resistance 01/2023 - 01/2011
6	Body Weight (Weight, Body) 12/2021 - 04/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 05/2012
4	Neuroinflammatory Diseases 12/2022 - 01/2019
3	Hyperpigmentation 12/2022 - 01/2013
3	Hypopigmentation (Hypomelanosis) 04/2020 - 03/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 08/2015
3	Colonic Neoplasms (Colon Cancer) 11/2016 - 01/2013
2	Carcinogenesis 02/2024 - 01/2011
2	Cognitive Dysfunction 01/2023 - 10/2012
2	Depressive Disorder (Melancholia) 12/2022 - 12/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2018
2	Non-alcoholic Fatty Liver Disease 11/2019 - 04/2018
2	Knee Osteoarthritis 01/2018 - 07/2017
2	Pain (Aches) 07/2017 - 11/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2014 - 01/2014
2	Pheochromocytoma 05/2012 - 09/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Anemia 09/2023
1	Overweight 08/2023

Drug/Important Bio-Agent (IBA)

10	AntioxidantsIBA 04/2024 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
7	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2011
6	LipidsIBA 08/2023 - 01/2002
6	oleuropeinIBA 01/2023 - 01/2009
6	3-methylquercetinIBA 12/2022 - 01/2015
6	FlavonoidsIBA 01/2020 - 05/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2013
5	EnzymesIBA 04/2020 - 01/2011
5	Insulin (Novolin)FDA Link 01/2020 - 08/2015
5	Triglycerides (Triacylglycerol)IBA 01/2018 - 04/2008
5	Hexosaminidases (Hexosaminidase)IBA 10/2013 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 07/2012
4	Ethanol (Ethyl Alcohol)IBA 04/2023 - 01/2013
4	Melanins (Melanin)IBA 12/2022 - 12/2007
4	AcidsIBA 01/2022 - 03/2011
4	mezereinIBA 08/2018 - 05/2009
4	DiterpenesIBA 08/2018 - 05/2009
4	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017 - 01/2013
4	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 01/2015 - 04/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 08/2017
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2023 - 01/2019
3	Olive OilIBA 06/2023 - 01/2009
3	Antidepressive Agents (Antidepressants)IBA 12/2022 - 01/2019
3	Neuroprotective AgentsIBA 01/2020 - 03/2011
3	CholesterolIBA 01/2020 - 04/2008
3	maslinic acidIBA 01/2018 - 11/2016
3	acteosideIBA 10/2013 - 10/2010
2	SqualeneIBA 03/2024 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 09/2023 - 01/2011
2	TeaIBA 08/2023 - 01/2019
2	CollagenIBA 05/2022 - 02/2016
2	argan oilIBA 08/2021 - 01/2013
2	cyanidinIBA 06/2021 - 01/2011
2	Anthocyanins (Anthocyanin)IBA 06/2021 - 01/2011
2	LuteolinIBA 03/2021 - 01/2021
2	Amyloid beta-PeptidesIBA 01/2020 - 05/2011
2	caffeoylquinic acidIBA 01/2020 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 09/2010
2	CytokinesIBA 01/2019 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2018
2	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 08/2017 - 11/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2016 - 04/2016
2	LDL CholesterolIBA 10/2014 - 04/2008
2	ApigeninIBA 09/2014 - 02/2013
2	Therapeutic UsesIBA 01/2014 - 01/2011
2	olive leaf extractIBA 01/2014 - 05/2007
2	GenisteinIBA 12/2013 - 11/2002
2	Plant ExtractsIBA 10/2013 - 10/2009
2	Immunoglobulin E (IgE)IBA 10/2013 - 03/2011
2	Mitogen-Activated Protein KinasesIBA 10/2013 - 03/2013
2	PolyphenolsIBA 01/2013 - 05/2012
2	HDL CholesterolIBA 01/2013 - 04/2008
2	3,5-dicaffeoylquinic acidIBA 10/2012 - 01/2011
2	Messenger RNA (mRNA)IBA 07/2012 - 01/2011
2	nitroxylIBA 11/2011 - 05/2011
2	fulvic acidIBA 03/2011 - 10/2009
2	beta-N-AcetylhexosaminidasesIBA 10/2009 - 05/2007
1	Synthetic DrugsIBA 01/2024
1	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA 01/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2023
1	BI D1870IBA 10/2023
1	HematinicsIBA 09/2023
1	oleaceinIBA 06/2023

Therapy/Procedure

8	Therapeutics 02/2022 - 07/2012
3	Oral Administration 01/2023 - 08/2018
2	Drug Therapy (Chemotherapy) 10/2023 - 05/2011
2	Chemoprevention 12/2013 - 02/2013